Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
symbol logo$IMDX Q2 '26 Earnings Results & Recap Insight Molecular Diagnostics Inc. reported Q2 2026 revenue of approximately $239,000 with a gross profit of $157,000, representing a 65.7% gross margin, while the net loss reached $11.3 million for the quarter.

Price since post

Full Details

Advertisement|Remove ads.